arrow
A

Atsushi Matsuda

distribution company
H指数:35
被引数:5,657

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TAK-500 is a clinical stage immune-cell directed antibody drug conjugate (iADC) inducing STING activation in CCR2-expressing intratumor myeloid cells and favorable immunomodulation

TAK-500是一种临床阶段的免疫细胞定向抗体药物偶联物 (iADC),可诱导CCR2-expressing肿瘤内髓样细胞的STING激活和良好的免疫调节

2023-04-040
PRE
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route
2021-05-1727
OAAI
Identification of U11snRNA as an endogenous agonist of TLR7-mediated immune pathogenesis

鉴定U11snRNA作为TLR7-mediated免疫发病机制的内源性激动剂

2019-11-0615
OAAI